Saturday, July 24, 2021
wellness India Expo
Home Tags Trials

Tag: Trials

Phase-3 trial results show COVAXIN is 77.8% effective against symptomatic COVID-19

Efficacy analysis demonstrates COVAXIN to be 93.4% effective against severe symptomatic COVID-19. Efficacy data demonstrates 65.2% protection against the SARS-CoV-2, B.1.617.2 Delta variant..................................

COVAXIN demonstrates interim clinical efficacy of 78% in phase 3 trials

The second interim results showed India’s First COVID-19 Vaccine had demonstrated strong primary efficacy against severe COVID-19 disease.......................

2020 has made clinical research even more significant: Experts at ISCR’s...

Speaking at the 14th Annual Conference of Indian Society for Clinical Research (ISCR), clinical research industry experts and academic members called for the collaborative effort of stakeholders during the pandemic and after....................

Allow Bt Brinjal trials in India, Alliance for Agri Innovation urges...

As per Alliance for Agri Innovation (AAI), a special interest group of Federation of Seed Industry of India (FSII), field trials are the only way to ensure safety of crops and blocking such these amounts to blocking national development..................

IQVIA & AstraZeneca team-up to support development of potential COVID-19 vaccine

Operation Warp Speed is part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.......................

Sun Pharma seals US$ 145 million deal with SPARC over potential...

The two companies have announced a worldwide licensing agreement on the development and commercialization of SCD-044 which is being evaluated as a potential oral treatment for atopic dermatitis, psoriasis and other auto-immune disorders.............

BD inaugurates Centre of Excellence in Clinical Flow Cytometry at AIMS,...

The new centre is aimed at increasing clinical research capabilities in India................

AstraZeneca set to expand its clinical research footprint in India

The establishment of a new Development Operations Centre by AstraZeneca at Bengaluru supports the development of innovative medicines and hosts clinical trial experts focused on core therapeutic areas................

Vyome Therapeutics begins phase 2 trial of its drug for acne...

The company has dosed the first patient in its Phase 2 trial of the Company’s lead clinical candidate, VB-1953, for the treatment of moderate to severe inflammatory acne vulgaris......................

Orthopedic prosthetics to get a facelift with successful research trials in...

In addition to the wide availability of technically advanced orthopedic prosthetics, escalating demand for custom-made orthopedic prosthetics is likely to push the growth of the global orthopedic prosthetics market in the next decade...................